Cloning of dopamine, norepinephrine and serotonin transporters from monkey brain: Relevance to cocaine sensitivity

Molecular Brain Research

Volumn 87, Issue 1, 2001, Pages 124-143

  Miller, Gregory M ^a   Yatin, Servet M ^a   De La Garza II, Richard ^a,b   Goulet, Martin ^a,c   Madras, Bertha K ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c REPLIGEN CORPORATION   (United States)

Author keywords

Addiction; ADHD; Monoamine; Phosphorylation; Polymorphism; Reuptake

Indexed keywords

AMFEBUTAMONE; ARGININE; CITALOPRAM; COCAINE; DESIPRAMINE; DOPAMINE; DOPAMINE TRANSPORTER; DOPAMINE UPTAKE INHIBITOR; FLUOXETINE; GLUTAMINE; IMIPRAMINE; LEUCINE; MAZINDOL; MESSENGER RNA; METHYLPHENIDATE; NISOXETINE; NORADRENALIN; NORADRENALIN TRANSPORTER; PHENYLALANINE; PROLINE; SEROTONIN; SEROTONIN TRANSPORTER; TALSUPRAM; VANOXERINE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BRAIN TISSUE; CONTROLLED STUDY; DRUG BINDING; DRUG SENSITIVITY; DRUG UPTAKE; EXON; IC 50; MOLECULAR CLONING; MONKEY; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN DETERMINATION; SEQUENCE HOMOLOGY; SUBSTANCE ABUSE; TRANSPORT KINETICS;

AMINO ACID SEQUENCE; ANIMALS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BRAIN CHEMISTRY; CARRIER PROTEINS; CLONING, MOLECULAR; COCAINE; COCAINE-RELATED DISORDERS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; MACACA FASCICULARIS; MACACA MULATTA; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MOLECULAR SEQUENCE DATA; NERVE TISSUE PROTEINS; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; OLIGONUCLEOTIDE PROBES; POLYMORPHISM, GENETIC; RADIOLIGAND ASSAY; SAIMIRI; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SYMPORTERS; TRITIUM;

MACACA FASICULARIS; MACACA MULATTA; PRIMATES; SAIMIRI SCIUREUS;

EID: 0035910939     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(00)00288-6     Document Type: Article

References (96)

1. Intact coding region of the serotonin transporter gene in obsessive-compulsive disorder
2. Neurotransmitter transporters: Three distinct gene families
3. Acute regulation of norepinephrine transport: II. PKC-modulated surface expression of human norepinephrine transporter proteins
4. Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys
5. Cloning and expression of a functional serotonin transporter from rat brain
6. Regulated phosphorylation and trafficking of antidepressant-sensitive serotonin transporter proteins
7. Sequence and structure-based prediction of eukaryotic protein phosphorylation sites
8. Acute and chronic dopamine dynamics in a nonhuman primate model of recreational cocaine use
9. Hypothesis about the function of membrane-buried proline residues in transport proteins
10. Regulation of serotonin-2C receptor G-protein coupling by RNA editing
11. Immunocytochemical localization of the dopamine transporter in human brain
12. A novel functional polymorphism within the promoter of the serotonin transporter gene: Possible role in susceptibility to affective disorders
13. Association of attention-deficit disorder and the dopamine transporter gene
14. Mapping susceptibility loci in attention deficit hyperactivity disorder: Preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children
15. Regulated trafficking of the human dopamine transporter. Clathrin-mediated internalization and lysosomal degradation in response to phorbol esters
16. Long-term cocaine self-administration decreases striatal preproenkephalin mRNA in rhesus monkeys
17. A novel allelic variant of the human serotonin transporter gene regulatory polymorphism
18. Systematic screening for mutations in the coding region of the human serotonin transporter (5-HTT) gene using PCR and DGGE
19. Dopamine transporter density in patients with attention deficit hyperactivity disorder
20. Dopamine transporter loss and clinical changes in MPTP-lesioned primates
21. SPECT imaging of dopamine transporter sites in normal and MPTP-Treated rhesus monkeys
22. Rapid detection of Parkinson's disease by SPECT with altropane: A selective ligand for dopamine transporters
23. Smoked and intravenous cocaine in humans: Acute tolerance, cardiovascular and subjective effects
24. 11 C-WIN 35, 428 reveals marked declines in mild Parkinson's disease
25. Genetic association between dopamine transporter protein alleles and cocaine-induced paranoia
26. Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism
27. 3H]CFT) binds to multiple charge-states of the solubilized dopamine transporter in primate striatum
28. Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets
29. Systematic screening for DNA sequence variation in the coding region of the human dopamine transporter gene (DAT1)
30. 11C]-CFT and PET in a primate model of parkinsonism
31. Allelic variation of human serotonin transporter gene expression
32. In vivo association between alcohol intoxication, aggression, and serotonin transporter availability in nonhuman primates
33. Reduced central serotonin transporters in alcoholism
34. Genotype influences in vivo dopamine transporter availability in human striatum
35. Cloning of a serotonin transporter affected by antidepressants
36. Localization and dynamic regulation of biogenic amine transporters in the mammalian central nervous system
37. TMbase - A database of membrane spanning proteins segments
38. Phorbol esters increase dopamine transporter phosphorylation and decrease transport Vmax
39. Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson disease
40. Neurotransmitter transporters: Fruitful targets for CNS drug discovery
41. Prediction of dopamine transporter binding availability by genotype: A preliminary report
42. Time course of extracellular dopamine and behavioral sensitization to cocaine. I. Dopamine axon terminals
43. Severe depletion of cocaine recognition sites associated with the dopamine transporter in Parkinson's-diseased striatum
44. Cloning and expression of a cocaine-sensitive rat dopamine transporter
45. Parkinsonism-inducing neurotoxin MPP+: Uptake and toxicity in nonneuronal COS cells expressing dopamine transporter cDNA
46. Phorbol esters alter functions of the expressed dopamine transporter
47. Dominant negative isoform of rat norepinephrine transporter produced by alternative RNA splicing
48. Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: Effects of methylphenidate as measured by single photon emission computed tomography
49. PhosphoBase, a database of phosphorylation sites: Release 2.0
50. Studies of selected phenyltropanes at monoamine transporters
51. 123I]beta-CIT: Pharmacological characterization of brain uptake in nonhuman primates
52. Species differences in functions of dopamine transporter: Paucity of MPP+ uptake and cocaine binding in bovine dopamine transporter
53. Isolation of a cDNA encoding the human brain serotonin transporter
54. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region
55. Primary structure of the serotonin transporter in unipolar depression and bipolar disorder
56. Dopamine transporter: Transmembrane phenylalanine mutations can selectively influence dopamine uptake and cocaine analog recognition
57. Dopamine transporter proline mutations influence dopamine uptake, cocaine analog recognition, and expression
58. Cloning and expression of the bovine sodium- and chloride-dependent noradrenaline transporter
59. Imaging the dopamine transporter: A window on dopamine neurons
60. 3H] cocaine binding sites in caudate-putamen
61. Altropane, a SPECT or PET imaging probe for dopamine neurons: I. Dopamine transporter binding in primate brain
62. 3H]2 beta-carbomethoxy-3beta-(4-fluorophenyl)tropane
63. Technepine: A high-affinity 99m-technetium probe to label the dopamine transporter in brain by SPECT imaging
64. Nitrogen-based drugs are not essential for blockade of monoamine transporters
65. 123I]beta-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder
66. 123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography
67. Positron emission tomographic evidence of toxic effect of MDMA ('Ecstasy') on brain serotonin neurons in human beings
68. 11C]WIN 35, 428 binding in striatum are reduced by GDNF: PET studies in the vervet monkey
69. Membrane trafficking regulates the activity of the human dopamine transporter
70. 3-Aryl-2-carbomethoxybicyclo[3.2.1]oct-2-enes inhibit WIN 35, 428 binding potently and selectively at the dopamine transporter
71. Single nucleotide polymorphisms distinguish multiple dopamine transporter alleles in primates: Implications for association with attention deficit hyperactivity disorder and other neuropsychiatric disorders
72. Serotonin, dopamine and norepinephrine transporters in the central nervous system and their inhibitors
73. Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter
74. Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter
75. Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants
76. Biosynthesis, N-glycosylation, and surface trafficking of biogenic amine transporter proteins
77. Phosphorylation and regulation of antidepressant-sensitive serotonin transporters
78. Cocaine receptors on dopamine transporters are related to self-administration of cocaine
79. Pharmacological properties of naturally occurring variants of the human norepinephrine transporter
80. Modulation of serotonin transporter activity by a protein kinase C activator and an inhibitor of type 1 and 2A serine/threonine phosphatases
81. Amphetamine-induced loss of human dopamine transporter activity: An internalization-dependent and cocaine-sensitive mechanism
82. In vivo detection of short- and long-term MDMA neurotoxicity - A positron emission tomography study in the living baboon brain
83. Modification of alcohol withdrawal by the A9 allele of the dopamine transporter gene
84. Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA
85. Tourette syndrome and the norepinephrine transporter gene: Results of a systematic mutation screening
86. A cognate dopamine transporter-like activity endogenously expressed in a COS-7 kidney-derived cell line
87. Altered striatal dopamine re-uptake site densities in habitually violent and non-violent alcoholics
88. DNA sequence polymorphisms in genes involved in the regulation of dopamine and serotonin metabolism in rhesus macaques
89. Transporter explosion: Update on uptake
90. Human dopamine transporter gene: Coding region conservation among normal. Tourette's disorder, alcohol dependence and attention-deficit hyperactivity disorder populations
91. 11C]WIN-35, 428 positron emission tomography studies and direct in vitro determinations
92. 123I]-beta-CIT SPECT imaging shows reduced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorder
93. 3′- and 4′-chloro-substituted analogs of benztropine: Intravenous self-administration and in vitro radioligand binding studies in rhesus monkeys
94. Molecular cloning of the mouse dopamine transporter and pharmacological comparison with the human homologue
95. Cocaine and dopamine: Differential effects on dopamine transporter distribution